New ACT-Accelerator strategy calls for US$ 23.4 billion international in for COVID-19 vaccines, tests & treatmentsvestment

New ACT-Accelerator strategic plan sets out urgent actions to address crucial gaps in access to COVID-19 tests, treatments, vaccines and personal protective equipment in low- and middle-income countries, using the latest epidemiological, supply and market information.